Factor XIIa activation of plasminogen is enhanced by contact activating surfaces and Zn2+

Blood Coagulation and Fibrinolysis

Volumn 8, Issue 2, 1997, Pages 97-104

  Schousboe, I ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

activation; factor XIIa; plasminogen

Indexed keywords

AMINOCAPROIC ACID; BLOOD CLOTTING FACTOR 12A; PHOSPHOLIPID; PLASMINOGEN; SULFATIDE; ZINC;

ARTICLE; CONTROLLED STUDY; HUMAN; PRIORITY JOURNAL;

EID: 0030980764     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001721-199703000-00003     Document Type: Article

References (23)

1. Glueck HI, Roehill W. Myocardial infarction in a patient with Hageman (factor XII) defect. Ann Intern Med 1966; 64: 390-396.
2. Hedner U, Nilsson IM. Acquired anticoagulants against factor XI and XII in patients with severe thrombotic disease. 16th Internat Congr Hematology Kyoto, Japan, 1976; (abstract no. 8/88): 341.
3. Levi M, Hack CE, de Boer JP, Brandjes DPM, Büller HR, Wouter ten Gate J. Reduction of contact activation related fibrinolytic activity in factor XII deficient patients. Further evidence for the role of the contact system in fibrinolysis in vivo. J Clin Invest 1991; 88: 1155-1160.
4. Hedner U, Martinsson G. Inhibition of activated Hageman factor (factor XIIa) by an inhibitor of the plasminogen activation (PA inhibitor). Thromb Res 1978; 12: 1015-1023.
5. Winter M, Gallimore M, Jones DW. Should factor XII assays be included in thrombophilia screening? Lancet 1995; 346: 52.
6. Loscalzo J, Braunwald E. Tissue plasminogen activation. N Engl J Med 1988; 319: 925-931.
7. Ichinose A, Fujikawa K, Suyama T. The activation of pro-urokinase by plasma kallikrein and its inactivation by thrombin. J Biol Chem 1986; 261: 3486-3489.
8. Petersen TE, Martzen MR, Ichinose A, Davie EW. Characterization of the gene for human plasminogen, a key proenzyme in the fibrinolytic system. J Biol Chem 1990; 265: 6104-6111.
9. Takada A, Sugawara Y, Takada Y. Enhancement of the activation of Glu-plasminogen by urokinase in the simultaneous presence of tranexamic acid or fibrin. Haemostasis 1989; 1: 26-34.
10. Goldsmith GH, Saito H, Ratnoff OD. The activation of plasminogen by Hageman factor (factor XII) and Hageman factor fragments. J Clin Invest 1978; 62: 54-60.
11. Bernardo MM, Day DE, Olson ST, Shore JD. Surface-independent acceleration of factor XII activation by zinc ions. I: Kinetic characterization of the metal ion rate enhancement. J Biol Chem 1993; 268: 12468-12476.
12. Bernardo MM, Day DE, Halvorson HR, Olson ST, Shore JD. Surface-independent acceleration of factor XII activation by zinc ions. II: Direct binding and fluorescence studies. J Biol Chem 1993; 268: 12477-12483.
13. Schousboe I. Contact activation in human plasma is triggered by zinc ion modulation of factor XII (Hageman factor). Blood Coag Fibrinol 1993; 4: 671-678.
14. Creighton-Kempsford LJ, Pring JB, Gaffney PJ. A comparison of the plasminogen activator activity units of urinary-type plasminogen activator (u-PA) and tissue-type plasminogen activator (t-PA). Blood Coag Fibrinol 1992; 3: 481-483.
15. Wu H-L, Chang B-I, Wu D-H, Chang L-C, Gong C-C, Lou K-L, Shi G-Y. Interaction of plasminogen and fibrin in plasminogen activation. J Biol Chem 1990; 265: 19658-19664.
16. Jespersen J, Gram J, Astrup T. The autodigestion of human plasmin follows a bimolecular mode of reaction subject to product inhibition. Thromb Res 1986; 41: 395-404.
17. Oster O, Dahm M, Oelert H, Prellwitz W. Concentration of some trace elements (Sc, Zn, Cu, Fe, Mg, K) in blood and heart tissue of patients with coronary heart disease. Clin Chem 1989; 35: 851-856.
18. Røjkjœr R, Schousboe I. The surface-dependent autoactivation mechanism of factor XII. Eur J Biochem 1997; 243: 160-166.
19. Henkin JK, Marcotte P, Yand H. The plasminogen-plasmin system. Prog Cardiovasc Dis 1991; 34: 135-164.
20. Christensen U. The AH-site of plasminogen and two C-terminal fragments. A weak lysine-binding site preferring ligands not carrying a free carboxylate function. Modern J 1984; 223: 413-421.
21. Wiman BL, Boman D, Collen D. On the kinetics of the reaction between human antiplasmin and a low molecular weight form of plasmin. Eur J Biochem 1978; 87: 143-146.
22. Thorsen S. Differences in the binding to fibrin of native plasminogen and plasminogen modified by proteolytic degradation. Influence of omega-amino carboxylic acids. Biochem Biophys Acta 1976; 393: 55-63.
23. r kininogen. Eur J Biochem 1991; 197: 309-314.